Pyxus inks agreement with Turning Point to initiate PMTA submission
Category: #business  By Mateen Dalal  Date: 2020-02-07
  • share
  • Twitter
  • Facebook
  • LinkedIn

Pyxus inks agreement with Turning Point to initiate PMTA submission

Pyxus International, Inc., one of the leading value-added agricultural companies in the world, has reportedly collaborated with Turning Point Brands, a leading company in OTP (Other Tobacco Products) and adult consumer alternatives.

Sources cite that the two companies have agreed to share certain testing data and science-based research to form the foundation of some of their respective PMTAs (Premarket Tobacco Product Applications) before being submitted to U.S. FDA (Food and Drug Administration).

According to reports, Turning Point Brands has inked a supply agreement for its house brands of e-liquids, thereby extending its existing collaboration with Pyxus' joint venture, Purilum, LLC, a manufacturer of high-quality e-liquids, finished bottles, and flavor concentrates products.

Apparently, all tobacco products modified or introduced after Feb. 15, 2007, require premarket permission by the FDA to be commercially marketed in the US. Pursuant to the FDA guidance, all PMTAs are due by 12 May 2020.

Reportedly, both companies will share several costs and key data related to extensive studies conducted to support their PMTAs filings. Additionally, Purilum presently offers the flavor formulations for a few of TPB's innovative products.

Pieter Sikkel, President, CEO and Chairman of Pyxus, said that the company needs likeminded, reputable partners to meet the stringent requirements of the U.S. FDA.

He added that Turning Point Brands, which presently has a strong relationship with the company’s joint venture Purilum, has constantly shown their commitment to quality and compliance. The company is pleased to partner with them to benefit respective PMTAs.

Graham Purdy, COO of Turning Point Brands, said that Purilum has garnered a reputation for excellence in e-liquid production and flavor formulation. Moreover, the consistency and quality of their products are exemplary, and the company is excited to continue to work with them over the next decades.

Both Turning Point Brands and Pyxus anticipate the filing of their respective PMTAs before the May filing deadline.

Source Credit - https://www.prnewswire.com/news-releases/pyxus-signs-agreement-with-turning-point-brands-initiating-pmta-project-collaboration-300999171.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

3CLogic focuses on global expansion, declares Series B funding round
3CLogic focuses on global expansion, declares Series B funding round
By Mateen Dalal

Cloud contact center solution provider 3CLogic has apparently declared a Series B financing round worth USD 9 million. Reliable reports claim that the round was mainly led by True Blue Partners and Capitan Investment Partners, while the other partici...

miDiagnostics secures €14M to commercialize rapid clinical testing
miDiagnostics secures €14M to commercialize rapid clinical testing
By Mateen Dalal

Leuven-based biotech firm miDiagnostics has recently concluded a €14 million investment round. The funding round was led by leading life science and technology investors, including Dr. Ir. Urbain Vandeurzen and Dr. Rudi Pauwels, as well as exist...

ATUM to offer Protein Synthesis Platform to COVID-19 test tool developers
ATUM to offer Protein Synthesis Platform to COVID-19 test tool developers
By Mateen Dalal

As the coronavirus pandemic reaches community level, prominent companies have come forward to aid medical researchers in accelerating their drug development process. ATUM, an American biotechnology firm, recently made a similar move when it revealed ...